$239 Million is the total value of Saturn V Capital Management LP's 20 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $33,504,459 | +98.1% | 1,126,579 | +20.0% | 14.02% | +49.5% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $17,432,669 | +37.1% | 1,810,246 | +28.2% | 7.30% | +3.5% |
| COGT | Buy | COGENT BIOSCIENCES INC | $17,310,296 | +27.9% | 1,775,415 | +55.3% | 7.24% | -3.5% |
| CBAY | Sell | CYMABAY THERAPEUTICS INC | $16,765,684 | +28.9% | 1,124,459 | -5.3% | 7.02% | -2.7% |
| BIIB | Buy | BIOGEN INC | $16,622,379 | +42.2% | 64,676 | +57.6% | 6.96% | +7.3% |
| New | AMYLYX PHARMACEUTICALS INC | $16,225,278 | – | 886,143 | +100.0% | 6.79% | – | |
| CYTK | Buy | CYTOKINETICS INC | $14,587,649 | +10.1% | 495,168 | +21.9% | 6.11% | -16.9% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $14,352,569 | +132.1% | 118,401 | +119.3% | 6.01% | +75.1% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $12,846,796 | +25.5% | 111,045 | +11.6% | 5.38% | -5.3% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $11,731,710 | +222.7% | 807,969 | +365.1% | 4.91% | +143.4% |
| ITOS | Buy | ITEOS THERAPEUTICS INC | $10,892,578 | +29.3% | 994,756 | +56.4% | 4.56% | -2.4% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $10,531,972 | +50.4% | 112,473 | +43.4% | 4.41% | +13.5% |
| ANAB | New | ANAPTYSBIO INC | $10,364,734 | – | 577,101 | +100.0% | 4.34% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $9,704,929 | +20.9% | 109,685 | +18.4% | 4.06% | -8.8% |
| Buy | ASTRIA THERAPEUTICS INC | $9,094,434 | +71.2% | 1,219,093 | +91.1% | 3.81% | +29.1% | |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $6,955,803 | +3.5% | 982,458 | +2.9% | 2.91% | -21.9% |
| ARGX | Buy | ARGENX SEsponsored adr | $4,952,681 | +211.4% | 10,074 | +146.9% | 2.07% | +135.0% |
| MORF | Sell | MORPHIC HLDG INC | $3,132,782 | -64.1% | 136,743 | -10.3% | 1.31% | -72.9% |
| New | JASPER THERAPEUTICS INC | $970,910 | – | 1,387,015 | +100.0% | 0.41% | – | |
| MRUS | New | MERUS N V | $944,756 | – | 40,066 | +100.0% | 0.40% | – |
| Exit | SCILEX HOLDING CO | $0 | – | -10,390 | -100.0% | -0.03% | – | |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -70,559 | -100.0% | -1.84% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -107,406 | -100.0% | -5.43% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -524,811 | -100.0% | -11.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CRINETICS PHARMACEUTICALS IN | 4 | Q3 2023 | 14.0% |
| CYMABAY THERAPEUTICS INC | 4 | Q3 2023 | 10.6% |
| CYTOKINETICS INC | 4 | Q3 2023 | 7.4% |
| KALVISTA PHARMACEUTICALS INC | 4 | Q3 2023 | 7.3% |
| HORIZON THERAPEUTICS PUB L | 4 | Q3 2023 | 8.1% |
| BIOGEN INC(NSM) | 4 | Q3 2023 | 7.8% |
| ASCENDIS PHARMA A/S - ADR | 4 | Q3 2023 | 6.6% |
| ITEOS THERAPEUTICS INC | 4 | Q3 2023 | 5.8% |
| MORPHIC HOLDING INC | 4 | Q3 2023 | 6.9% |
| BIOCRYST PHARMACEUTICALS INC | 4 | Q3 2023 | 7.2% |
View Saturn V Capital Management LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-09 |
View Saturn V Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.